Editor-in-Chief

Prof.

Ronald B. Moss,  Ansun BioPharma Inc., USA

Executive Editor-in-Chief

Dr.	Daniel Dennis Taub,  Clinical Immunology Section, USA

Editorial Board

Prof.	Jonathan B. Angel,  University of Ottawa, Canada
Prof.	Luz Pámela Blanco,  University of Michigan, USA
Prof.	Steven Douglas,  University of Pennsylvania, USA
Dr.	Marc Gurwith,  PaxVax, Inc., USA
Dr.	Wayne R. Hogrefe,  Clinical Trials Program, USA
Dr.	Zhiwei Hu,  The Ohio State University, USA
Dr.	Pankaj Kumar,  University of Saskatchewan, Canada
Dr.	Mohan S. Maddur,  Emory University School of Medicine, USA
Dr.	Robert W. Malone,  Beardsworth Consulting Group, Inc., USA
Dr.	Godfred Antony Menezes,  Hail University, Saudi Arabia
Prof.	Thomas Moll,  Adamis Pharmaceuticals Corporation, USA
Prof.	William J. Murphy,  University of California, USA
Dr.	Savita Nair,  Fox Chase Cancer Center Temple Health, USA
Prof.	Jose Ignacio Santos,  National Autonomous University of Mexico, Mexico
Prof.	Richard Schwartz,  Michigan State University, USA
Prof.	Sherven Sharma,  University of California at Los Angeles, USA
Dr.	Xiaobin Tang,  Stanford University School of Medicine, USA